Optimizing paclitaxel/epirubicin treatment in advanced breast cancer

被引：0
|
作者：
Conte, PF [1 ]
Gennari, A [1 ]
机构：
[1] St Chiara Hosp, Dept Med Oncol, Pisa, Italy
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
    Ron, IG
    Sarid, DL
    Wigler, N
    Inbar, MJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
  • [22] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
    Sarid, David
    Ron, Ilan G.
    Sperber, Fani
    Stadler, Yona
    Kahan, Perry
    Kovner, Felix
    Ben-Yosef, Rami
    Marmor, Sylvia
    Grinberg, Yulia
    Maimon, Natalie
    Weinstein, Juliana
    Yaal-Hahoshen, Neora
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
  • [23] Docetaxel and epirubicin in advanced breast cancer
    Sessa, C
    Pagani, O
    [J]. ONCOLOGIST, 2001, 6 : 13 - 16
  • [24] Weekly Paclitaxel - An Effective Treatment for Advanced Breast Cancer
    Kellokumpu-Lehtinen, Pirkko
    Tuunanen, Tuija
    Asola, Raija
    Elomaa, Liisa
    Heikkinen, Mirja
    Kokko, Riitta
    Jarvenpaa, Ritva
    Lehtinen, Ilari
    Maiche, Abdel
    Kaleva-Kerola, Jaana
    Huusko, Mauri
    Moykkynen, Kari
    Ala-Luhtala, Timo
    [J]. ANTICANCER RESEARCH, 2013, 33 (06) : 2623 - 2627
  • [25] Cisplatin-epirubicin-paclitaxel (PET) weekly administration vs. epirubicin-paclitaxel (ET) in locally advanced or metastatic breast cancer.
    Maiorino, LG
    Frasci, G
    D'Aiuto, G
    Comello, P
    Cartenì, P
    Thomas, R
    Capasso, I
    Cortino, GR
    DeCataldis, G
    Silvestro, L
    Russo, A
    Di Bonito, M
    Comella, G
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 45 - 45
  • [26] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    [J]. JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [27] Epirubicin in the treatment of breast cancer
    Perez-Lopez, FR
    [J]. XI INTERNATIONAL CONGRESS OF SENOLOGY, 2000, : 47 - 66
  • [28] Weekly cisplatin-epirubicin-paclitaxel in advanced breast cancer. A phase I study
    Frasci, G
    Comella, P
    Apicella, A
    D'Aiuto, G
    Thomas, R
    Capasso, I
    Di Bonito, M
    Piccolo, S
    Carteni, G
    Gravina, A
    Comella, G
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
  • [29] Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial
    Focan, C
    Graas, MP
    Beauduin, M
    Canon, JL
    Salmon, JP
    Jerusalem, G
    Focan-Henrard, D
    Lobelle, JP
    Schallier, D
    [J]. ANTICANCER RESEARCH, 2005, 25 (2B) : 1211 - 1217
  • [30] Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?
    Sudeep Gupta
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 80 - 81
12345